$8.55
-$0.13
(-1.50%)
Quote as of 11:52 AM EST on 02/09/12
ISIS Pharmaceuticals, Inc.
NASDAQ:ISIS
|
$8.55
-$0.13
(-1.50%)
|
|
| Today's Open | $8.67 |
|---|---|
| Previous Close | $8.68 |
| Daily Range | $8.52 - $8.67 |
| 52-Week Range | $6.25 - $9.61 |
| Market Cap | $852.69M |
| P/E Ratio | -10.99 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 68,327 |
| Average Daily Volume | 606,568 |
| Current FY EPS | -$0.81 |
ISIS Information
| Description |
|---|
| The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
The Zacks Analyst Blog Highlights: General Motors, Toyota Motor, Ford Motor, Biogen Idec and Isis Ph
Isis-Biogen Team Up - Analyst Blog
Biogen, Isis Enter Collaboration On Spinal Atrophy Treatment
Pfizer Nets Excaliard Pharma - Analyst Blog
Back to Neutral on Isis Pharma - Analyst Blog
Pfizer Signs Another Deal - Analyst Blog
Pfizer Adds to Fibrosis Drug Pipeline With Excaliard Buyout
Morning Roundup: Today's Top Stories
Pfizer Acquires Excaliard, an Isis Spinout With Drug to Fight Excessive Scarring
Mid-Day Update: Stocks Lower at Session's Half; Revised GDP Data Weighs on Sentiment
